Vir Biotechnology, Inc. · NASDAQ:VIR
Sb Investment Advisers (UK) LTD reported a 6.50% stake in Vir Biotechnology, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Sb Investment Advisers (UK) LTD reported a 6.50% stake in Vir Biotechnology, Inc., 10,948,093 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 6.50%
- Shares
- 10,948,093
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SB Investment Advisers (UK) Limited | 6.50% | 10,948,093 |
| SoftBank Vision Fund (AIV M1) L.P. | 6.50% | 10,948,093 |
| SVF Endurance (Cayman) Limited | 6.50% | 10,948,093 |
Source
Related
- Vir Biotechnology, Inc.
- Sb Investment Advisers (UK) LTD
- Vir Biotechnology, Inc. shareholders
- Schedule 13G/A · Sb Investment Advisers (UK) LTD · Feb 17, 2026
- Form 4 · More Robert J · Aug 12, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4 · Coughlin Timothy · Jun 10, 2026
- Form 4 · Napolitano Janet · Jun 2, 2026